Neurocrine Biosciences, Inc. (NBIX) Surges After FDA Gives Green Light to Ingrezza
Shares of Neurocrine Biosciences, Inc.
Neurocrine Biosciences Inc (NBIX)
Market is closed
News
- First
- << Previous
- 61 - 70
- Next >>
Here Are Two Market Moving Biotech Catalysts To Watch This Week
The biotechnology sector is in full swing for the New Year, and while the JP Morgan conference is now in the rearview mirror, there are still plenty of potential catalysts set to hit press between now...
What Does The Panel Cancellation Mean For Neurocrine Biosciences, Inc. (NBIX)?
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) just announced that that the FDA has cancelled the Psychopharmacologic Drugs Advisory Committee meeting for INGREZZA.
Is Neurocrine Biosciences, Inc. (NBIX) a Good Stock to Buy?
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors' Q3 Returns; See How Other Investments Performed
Joseph Edelman's Perceptive Advisors is a fund that has an equity portfolio worth $1.44 billion as of the end of June, with over 80% of it being invested in healthcare stocks.
This Biotech Hedge Fund's Stock Picks Killed It in Q3
Hedge funds returned about 4% so far this year and underperformed the S&P 500 Index again.
Here’s Our Take On Neurocrine Biosciences, Inc. (NBIX)'s Ingrezza
Neurocrine Biosciences, Inc.
Blue Jay Capital Betting On Big Returns From These Healthcare Stocks
Founded by Paul Sinclair in August 2014, Blue Jay Capital Management is a healthcare-focused hedge fund based in California.
Top Biotech Picks of Best-Performing Hedge Fund of 2015
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top of the list was biotech-focused hedge fund Perceptive...
Four Stocks Driving Thursday’s Market Gains: How Did They Do It?
In the first eight days of the year, the S&P 500 index fell by roughly 7.5%, the Dow lost 7.3%, and the NASDAQ tumbled by 9.6%.
- First
- << Previous
- 61 - 70
- Next >>
Billionaire Hedge Funds
